VVP
TMO icon

Venture Visionary Partners’s Thermo Fisher Scientific TMO Stock Holding History

Venture Visionary Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.06M Sell
2,116
-2,800
-57% -$1.34M 0.03% 335
2026
Q1 		$2.42M Buy
4,916
+217
+5% +$118K 0.08% 198
2025
Q4 		$2.72M Buy
4,699
+1,358
+41% +$768K 0.09% 184
2025
Q3 		$1.62M Sell
3,341
-366
-10% -$170K 0.06% 237
2025
Q2 		$1.5M Buy
3,707
+472
+15% +$197K 0.06% 237
2025
Q1 		$1.61M Buy
3,235
+138
+4% +$74.7K 0.07% 223
2024
Q4 		$1.61M Sell
3,097
-68
-2% -$37.4K 0.07% 217
2024
Q3 		$1.96M Sell
3,165
-180
-5% -$107K 0.09% 191
2024
Q2 		$1.85M Buy
3,345
+246
+8% +$141K 0.09% 205
2024
Q1 		$1.8M Sell
3,099
-71
-2% -$39.8K 0.09% 202
2023
Q4 		$1.68M Buy
3,170
+2,239
+240% +$1.08M 0.09% 198
2023
Q3 		$471K Sell
931
-16
-2% -$8.53K 0.03% 342
2023
Q2 		$494K Sell
947
-194
-17% -$105K 0.03% 339
2023
Q1 		$658K Sell
1,141
-1,286
-53% -$725K 0.04% 294
2022
Q4 		$1.34M Buy
2,427
+160
+7% +$84.8K 0.1% 179
2022
Q3 		$1.15M Sell
2,267
-1,207
-35% -$675K 0.09% 177
2022
Q2 		$1.89M Buy
3,474
+5
+0.1% +$2.75K 0.14% 126
2022
Q1 		$2.05M Buy
3,469
+33
+1% +$19K 0.14% 139
2021
Q4 		$2.29M Buy
3,436
+80
+2% +$49.9K 0.15% 125
2021
Q3 		$1.92M Buy
3,356
+61
+2% +$33.5K 0.14% 137
2021
Q2 		$1.66M Buy
3,295
+226
+7% +$107K 0.13% 143
2021
Q1 		$1.4M Buy
3,069
+534
+21% +$255K 0.12% 159
2020
Q4 		$1.18M Buy
+2,535
New +$1.19M 0.13% 133

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Venture Visionary Partners's TMO Position: Q2 2026 in Review

Venture Visionary Partners reduced its Thermo Fisher Scientific (TMO) stake by 57% in Q2 2026, selling an estimated $1.34M and leaving 2,116 shares worth $1.06M. The position accounts for 0.03% of the portfolio, ranked #335.

Venture Visionary Partners first reported a position in TMO in Q4 2020 and has held it in 23 quarters since. The position peaked at $2.72M in Q4 2025. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Venture Visionary Partners held 2,116 shares of Thermo Fisher Scientific worth $1.06M as of Q2 2026.
  • Venture Visionary Partners sold 2,800 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.34M.
  • Thermo Fisher Scientific made up 0.03% of Venture Visionary Partners's portfolio in Q2 2026, its #335 holding.
  • Venture Visionary Partners first reported a position in Thermo Fisher Scientific in Q4 2020 and has held it in 23 quarters since.
  • Venture Visionary Partners's Thermo Fisher Scientific position peaked at $2.72M in Q4 2025.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Venture Visionary Partners's 13F filing for Q2 2026, filed 27 Jul 2026.